ABOUT US

Global Leader of Cancer Treatments

Leadership

  • CEO CEO
    • Tai (Tae Hun) KimCEO
      Boryung Pharm new drug(Kanarb) Global biz team head Huya bioscience San Diego, Licensing part

      Major success track record of global L/O

      - New drug(IMD) of Boryung Pharm., KT&G Life Science, Daewoong Pharm
  • CEO CEO
    • Charlie (SiChul) RohVP / Global BD
      GE healthcare Marketing team Boryung Pharm Overseas Biz team

      Major success track record of global L/O

      - New drug of Crystal Genomics, Ilyang Pharm, Boryung Pharm.
  • CEO CEO
    • Juneui ParkDirector / Chief of R&D center
      JW CreaGene Research Institute
      Genexine Clinical development team head Memorial Sloan-Kettering Cancer Center(NY) Doctor, Researcher (Dendritic cell, NKT cell) Roswell Park Cancer Institute(NY) Doctor, Biochemistry & Biophysics
  • r&d CEO
    • Chulho PARKBoard Member / R&D advisor
      Oncotelic, Co-founder & CTO Mabprex, Founder & CEO, San Diego, CA
      aTyr Pharma, Head of Biologics Eli Lilly & Company, Group Leader
  • professor CEO
    • Professor Jin Tae, HongNon-clinical and Toxicology advisor
      Principal of Pharmaceutical College of Chungbuk National University Professor of Chungbuk National University Chief of Medical Research Center of Chungbuk National University Former Osong Medical Innovation Foundation Former MFDS researcher
  • CEO CEO
    • Hyung Geun Song M.D.,Ph.D.Clinical pathology advisor
      Professor of Chungbuk National University of Medicine CEO of DiNonA SNU Medical school pathology resident Visiting fellow, RPMI institute, USA
  • CEO CEO
    • Sung Hwa Hong ProfessorRA advisor
      Sartorius Korea Biotech Senior VP Prof. Chungbuk National University of pharmacy MFDS Safety Evaluation division MFDS Bio product division
  • CEO CEO
    • Young Jun Park ProfessorFormulation Advisor
      Prof. of Ajou Univ. school of pharmacy MFDS RA advisor MFDS Drug Evaluation Advisor